MITAKY

MITAKY is a Japanese technology company.

Questions & answers

Q1. Is ADSC therapy safe?

“Yes, ADSC therapy is safe as it uses autologous cells (your own), minimising the risk of immune rejection and adverse reactions. All procedures are conducted under stringent medical guidelines in CPC-certified facilities by Japan’s Ministry of Health, Labour & Welfare, to ensure the highest standards of safety and quality.”

Q2. Is immune cell therapy safe?

“Yes, immune cell therapy is generally safe because it uses the patient’s own immune cells, which eliminates the risk of rejection or severe allergic reactions. The procedures involved, such as blood collection and reinfusion, are minimally invasive.”

Data formats & record details

Download this profile and inspect its supporting evidence.

Entity ID
urn:readyscan:entity:mitaky-q125422561
Material fingerprint
fnv1a64:5666fd207f417848
Entity revision
fnv1a64:dd4de6098eabcac4
Published
2026-10-22
Modified
2026-10-22
Source summary
MITAKY: Japanese technology company. Website: https://mitaky.co.jp/